|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/22/2024 |
$0.47 |
$0.58 |
$0.47 |
$0.57 |
1.78M | 03/25/2024 |
$0.60 |
$0.79 |
$0.57 |
$0.66 |
4.71M | 03/26/2024 |
$0.70 |
$0.72 |
$0.62 |
$0.66 |
1.50M | 03/27/2024 |
$0.66 |
$0.69 |
$0.51 |
$0.60 |
1.30M | 03/28/2024 |
$0.58 |
$0.60 |
$0.48 |
$0.56 |
646.90K |
|
BrainStorm Cell Therapeutics is a biotechnology company engaged in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases including: Amyotrophic Lateral Sclerosis; Progressive Multiple Sclerosis; Alzheimer's disease; and other neurodegenerative diseases. NurOwn®, Co.'s proprietary cell therapy platform, utilizes cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival and improve neurological function. | |
|
Brainstorm Cell Therapeutics (BCLI) has the following price history information. Looking back at BCLI historical stock prices for the last five trading days, on March 22, 2024, BCLI opened at $0.47, traded as high as $0.58 and as low as $0.47, and closed at $0.57. Trading volume was a total of 1.78M shares. On March 25, 2024, BCLI opened at $0.60, traded as high as $0.79 and as low as $0.57, and closed at $0.66. Trading volume was a total of 4.71M shares. On March 26, 2024, BCLI opened at $0.70, traded as high as $0.72 and as low as $0.62, and closed at $0.66. Trading volume was a total of 1.50M shares. On March 27, 2024, BCLI opened at $0.66, traded as high as $0.69 and as low as $0.51, and closed at $0.60. Trading volume was a total of 1.30M shares. On March 28, 2024, BCLI opened at $0.58, traded as high as $0.60 and as low as $0.48, and closed at $0.56. Trading volume was a total of 646.90K shares.
BCLI Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Brainstorm Cell Therapeutics shares, starting with a $10,000 purchase of BCLI, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/01/2014 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$0.29 |
|
End price/share: |
$0.56 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
93.10% |
|
Average Annual Total Return: |
6.80% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$19,303.42 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
03/22/2024 | $0.57 | 03/25/2024 | $0.66 | 03/26/2024 | $0.66 | 03/27/2024 | $0.60 | 03/28/2024 | $0.56 |
|
|